262 related articles for article (PubMed ID: 12606780)
1. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.
Offertáler L; Mo FM; Bátkai S; Liu J; Begg M; Razdan RK; Martin BR; Bukoski RD; Kunos G
Mol Pharmacol; 2003 Mar; 63(3):699-705. PubMed ID: 12606780
[TBL] [Abstract][Full Text] [Related]
2. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1.
Mo FM; Offertáler L; Kunos G
Eur J Pharmacol; 2004 Apr; 489(1-2):21-7. PubMed ID: 15063151
[TBL] [Abstract][Full Text] [Related]
3. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.
Ho WS; Hiley CR
Br J Pharmacol; 2003 Apr; 138(7):1320-32. PubMed ID: 12711633
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
[TBL] [Abstract][Full Text] [Related]
5. Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.
Schmuhl E; Ramer R; Salamon A; Peters K; Hinz B
Biochem Pharmacol; 2014 Feb; 87(3):489-501. PubMed ID: 24304686
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current.
Begg M; Mo FM; Offertaler L; Bátkai S; Pacher P; Razdan RK; Lovinger DM; Kunos G
J Biol Chem; 2003 Nov; 278(46):46188-94. PubMed ID: 12952947
[TBL] [Abstract][Full Text] [Related]
7. Role of Endothelium in Abnormal Cannabidiol-Induced Vasoactivity in Retinal Arterioles.
Su EN; Kelly ME; Cringle SJ; Yu DY
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4029-37. PubMed ID: 26098470
[TBL] [Abstract][Full Text] [Related]
8. 2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1/2 signaling.
Su JY; Vo AC
Eur J Pharmacol; 2007 Mar; 559(2-3):189-95. PubMed ID: 17292352
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
10. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
[TBL] [Abstract][Full Text] [Related]
11. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
Bisogno T; Hanus L; De Petrocellis L; Tchilibon S; Ponde DE; Brandi I; Moriello AS; Davis JB; Mechoulam R; Di Marzo V
Br J Pharmacol; 2001 Oct; 134(4):845-52. PubMed ID: 11606325
[TBL] [Abstract][Full Text] [Related]
12. Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow-enhancing effects of abnormal-cannabidiol.
Qiao Z; Kumar A; Kumar P; Song ZH
Exp Eye Res; 2012 Jul; 100():59-64. PubMed ID: 22580290
[TBL] [Abstract][Full Text] [Related]
13. Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor.
Hoi PM; Hiley CR
Br J Pharmacol; 2006 Mar; 147(5):560-8. PubMed ID: 16415907
[TBL] [Abstract][Full Text] [Related]
14. Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat.
Hoi PM; Visintin C; Okuyama M; Gardiner SM; Kaup SS; Bennett T; Baker D; Selwood DL; Hiley CR
Br J Pharmacol; 2007 Nov; 152(5):751-64. PubMed ID: 17891160
[TBL] [Abstract][Full Text] [Related]
15. Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent.
Mukhopadhyay S; Chapnick BM; Howlett AC
Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2046-54. PubMed ID: 12003810
[TBL] [Abstract][Full Text] [Related]
16. Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery.
Ho WS; Hiley CR
J Pharm Pharmacol; 2004 Jul; 56(7):869-75. PubMed ID: 15233865
[TBL] [Abstract][Full Text] [Related]
17. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
18. Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery.
Kozłowska H; Baranowska M; Schlicker E; Kozłowski M; Laudański J; Malinowska B
J Hypertens; 2007 Nov; 25(11):2240-8. PubMed ID: 17921818
[TBL] [Abstract][Full Text] [Related]
19. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
Fride E; Ponde D; Breuer A; Hanus L
Neuropharmacology; 2005 Jun; 48(8):1117-29. PubMed ID: 15910887
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of vasorelaxation induced by the cannabidiol analogue compound O-1602 in the rat small mesenteric artery.
Al Suleimani YM; Al Mahruqi AS; Hiley CR
Eur J Pharmacol; 2015 Oct; 765():107-14. PubMed ID: 26297305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
